Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/12209601

Int. J. Cancer 2002 Aug 20 100 6 642-53

Download in:

View as

General Info

PMID
12209601